Online inquiry

IVTScrip™ mRNA-Human AK7, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK18352MR)

This product GTTS-WK18352MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the AK7 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001350888.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 122481
UniProt ID Q96M32
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AK7, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK18352MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK18468MR IVTScrip™ mRNA-Human ANAPC11, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANAPC11
GTTS-WK16022MR IVTScrip™ mRNA-Human Alkaline phosphatase, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA Alkaline phosphatase
GTTS-WK9850MR IVTScrip™ mRNA-Human ADH7, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ADH7
GTTS-WK12621MR IVTScrip™ mRNA-Human AASDH, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA AASDH
GTTS-WK13908MR IVTScrip™ mRNA-Human ACADS, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ACADS
GTTS-WK21314MR IVTScrip™ mRNA-Human AGPS, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AGPS
GTTS-WK1438MR IVTScrip™ mRNA-Human PRSS50, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA PRSS50
GTTS-WK3873MR IVTScrip™ mRNA-Human CD203c, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA CD203c
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →